Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression-Reference-Cited by-同舟云学术

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression

Published:2004-05-01 Issue:5 Volume:27 Page:1250-1251
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Hirshberg Boaz¹,Rother Kristina I.¹,Digon Benigno J.¹,Harlan David M.¹

Affiliation:

1. From the Islet & Autoimmunity Branch, National Institute of Diabetes, Digestive and Kidney Disease (NIDDK), National Institutes of Health (NIH)/Department of Health and Human Services (DHHS), Bethesda, Maryland

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/27/5/1250/566065/1250.pdf

Reference5 articles.

1. Charles MA, Selam J-L: Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression (Letter). Diabetes Care 27:1249–1250, 2004

2. Hirshberg B, Rother KI, Digon BJ 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM: Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care 26:3288–3295, 2003

3. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM: Pancreas transplantation decreases survival for patients with diabetes and preserved kidney function. JAMA 290:2817–2823, 2003

4. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238, 2000

5. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M: Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care 25:2256–2262, 2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of a Sirolimus/Tacrolimus-Based Immunosuppressive Regimen on Kidney Function After Islet Transplantation;Transplantation Proceedings;2005-03

2. Embryonic stem cells and islet replacement in diabetes mellitus;Pediatric Diabetes;2004-12